Zhang, Y. (2018). Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationZhang, Y. Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationZhang, Y. Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.